AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 17 filers reported holding AKARI THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $54 | +3.8% | 318,250 | +12.2% | 0.00% | – |
| Q1 2023 | $52 | +100.0% | 283,550 | +411.4% | 0.00% | – |
| Q4 2022 | $26 | -99.9% | 55,450 | +38.5% | 0.00% | – |
| Q3 2022 | $25,000 | -45.7% | 40,050 | -12.8% | 0.00% | – |
| Q2 2022 | $46,000 | -17.9% | 45,950 | -0.6% | 0.00% | – |
| Q1 2022 | $56,000 | -37.8% | 46,250 | -23.3% | 0.00% | – |
| Q4 2021 | $90,000 | -15.9% | 60,289 | -7.7% | 0.00% | – |
| Q3 2021 | $107,000 | -59.2% | 65,350 | -56.8% | 0.00% | – |
| Q2 2021 | $262,000 | -25.1% | 151,396 | +14.0% | 0.00% | – |
| Q1 2021 | $350,000 | +75.9% | 132,751 | +23.3% | 0.00% | – |
| Q4 2020 | $199,000 | +5.3% | 107,652 | -0.9% | 0.00% | – |
| Q3 2020 | $189,000 | -35.1% | 108,646 | -18.7% | 0.00% | – |
| Q2 2020 | $291,000 | +54.8% | 133,646 | +3.2% | 0.00% | – |
| Q1 2020 | $188,000 | -37.5% | 129,446 | -24.7% | 0.00% | – |
| Q4 2019 | $301,000 | +29.7% | 171,931 | +26.8% | 0.00% | – |
| Q3 2019 | $232,000 | -15.0% | 135,630 | +0.5% | 0.00% | – |
| Q2 2019 | $273,000 | +301.5% | 135,000 | +610.5% | 0.00% | – |
| Q1 2019 | $68,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omnia Family Wealth, LLC | 467,085 | $761,000 | 0.52% |
| Hikari Power Ltd | 89,815 | $146,000 | 0.02% |
| NEA Management Company, LLC | 452,167 | $737,000 | 0.01% |
| Truvestments Capital LLC | 1,621 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,276 | $25,000 | 0.00% |
| MORGAN STANLEY | 5,539 | $9,000 | 0.00% |
| Renaissance Technologies | 65,350 | $107,000 | 0.00% |
| Citadel Advisors | 37,770 | $62,000 | 0.00% |
| HighTower Advisors, LLC | 20,000 | $33,000 | 0.00% |